Anebulo Pharmaceuticals Statistics Share Statistics Anebulo Pharmaceuticals has 41.08M
shares outstanding. The number of shares has increased by 58.43%
in one year.
Shares Outstanding 41.08M Shares Change (YoY) 58.43% Shares Change (QoQ) 0% Owned by Institutions (%) 55.05% Shares Floating 24.43M Failed to Deliver (FTD) Shares 1,833 FTD / Avg. Volume 0.45%
Short Selling Information The latest short interest is 416.32K, so 1.01% of the outstanding
shares have been sold short.
Short Interest 416.32K Short % of Shares Out 1.01% Short % of Float 5.95% Short Ratio (days to cover) 3.81
Valuation Ratios The PE ratio is -8.44 and the forward
PE ratio is -5.1.
Anebulo Pharmaceuticals's PEG ratio is
0.26.
PE Ratio -8.44 Forward PE -5.1 PS Ratio 0 Forward PS 5.8 PB Ratio 18.15 P/FCF Ratio -8.55 PEG Ratio 0.26
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Anebulo Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 13.46,
with a Debt / Equity ratio of 0.
Current Ratio 13.46 Quick Ratio 13.46 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage -54.94
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-4.1M Employee Count 2 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 32.78% in the
last 52 weeks. The beta is -0.89, so Anebulo Pharmaceuticals's
price volatility has been lower than the market average.
Beta -0.89 52-Week Price Change 32.78% 50-Day Moving Average 2.27 200-Day Moving Average 1.57 Relative Strength Index (RSI) 46.63 Average Volume (20 Days) 405,185
Income Statement
Revenue n/a Gross Profit n/a Operating Income -8.31M Net Income -8.2M EBITDA -8.05M EBIT -8.05M Earnings Per Share (EPS) -0.32
Full Income Statement Balance Sheet The company has 3.09M in cash and 0 in
debt, giving a net cash position of 3.09M.
Cash & Cash Equivalents 3.09M Total Debt n/a Net Cash n/a Retained Earnings -65.4M Total Assets 14.01M Working Capital 13.26M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -8.09M
and capital expenditures 0, giving a free cash flow of -8.09M.
Operating Cash Flow -8.09M Capital Expenditures n/a Free Cash Flow -8.09M FCF Per Share -0.31
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
